| 1. |
WHO. Global burden of disease website. [2020-10-15]. http:/www.who.int/topics/global_burden of disease.
|
| 2. |
GOLD. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. [2020-08-09]. https://goldcopd.org/gold-reports/.
|
| 3. |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2018, 68(6): 394-424.
|
| 4. |
戴偉, 王小文, 黃春, 等. 肺癌切除術后心房顫動發生的危險因素及發病機制研究進展. 上海交通大學學報(醫學版), 2018, 38(5): 573-577.
|
| 5. |
王小文, 黃春, 葛明建, 等. 胸腔鏡手術與傳統開胸術后心律失常發生率的前瞻性對比研究. 中華胸心血管外科學雜志, 2013, 29(1): 4-7.
|
| 6. |
陳偉, 馮天賜, 王小文, 等. 合并2型糖尿病的非小細胞肺癌患者肺切除術后近期預后的臨床分析. 中國胸心血管外科臨床雜志, 2020, 27(8): 912-917.
|
| 7. |
孫芳艷, 錢培芬. 慢性阻塞性肺疾病綜合肺康復方案的研究進展. 中華護理雜志, 2010, 45(8): 755-757.
|
| 8. |
Krzystek-Korpacka M, Matusiewicz M, Diakowska D, et al. Respiratory insufficiency related to COPD accelerates systemic inflammation, under-nutrition, and angiogenesis in esophageal malignancies. Exp Oncol, 2008, 30(1): 75-80.
|
| 9. |
Aggarwal BB, Shishodia S, Sandur SK, et al. Inflammation and cancer: how hot is the link? Biochem Pharmacol, 206, 72(11): 1605-1621.
|
| 10. |
Oudijk EJ, Lammers JW, Koenderman L. Systemic inflammation in chronic obstructive pulmonary disease. Eur Respir J Suppl, 2003, 46: 5s-13s.
|
| 11. |
崔玉尚, 張志庸, 阿伊都·阿布都熱伊木. 開胸術后早期肺功能的變化規律及影響因素分析. 中華外科雜志, 2003, 41(12): 909-912.
|
| 12. |
Kageyama S, Ikeda H, Miyahara Y, et al. Adoptive transfer of MAGE-A4 t-cell receptor gene-transduced lymphocytes in patients with recurrent esophageal cancer. Clin Cancer Res, 2015, 21(10): 2268-2277.
|
| 13. |
Ferguson MK, Celauro AD, Prachand V. Prediction of major pulmonary complications after esophagectomy. Ann Thorac Surg, 2011, 91(5): 1494-1500.
|
| 14. |
Ma G, Zhang X, Ma Q, et al. A novel multivariate scoring system for determining the prognosis of lymph node-negative esophageal squamous cell carcinoma following surgical therapy: An observational study. Eur J Surg Oncol, 2015, 41(4): 541-547.
|
| 15. |
Markar S, Gronnier C, Duhamel A, et al. Pattern of postoperative mortality after esophageal cancer resection according to center volume: Results from a large european multicenter study. Ann Surg Oncol, 2015, 22(8): 2615-2623.
|
| 16. |
Yoshida R, Morita M, Shoji F, et al. Clinical significance of SIP1 and E-cadherin in patients with esophageal squamous cell carcinoma. Ann Surg Oncol, 2015, 22(8): 2608-2614.
|
| 17. |
劉現海, 李峰, 路宏燕, 等. 肺功能指標對食管癌患者術后肺部感染的預測價值. 中華醫院感染學雜志, 2019, 29(9): 1379-1383.
|
| 18. |
于善海, 李德生, 伊力亞爾·夏合丁, 等. 食管癌切除術后并發癥多因素 Logistic 回歸分析及風險模型建立. 世界華人消化雜志, 2011, 19(34): 3508-3513.
|
| 19. |
陳曉珍, 張懷忠, 方韜. 食管癌術后并發癥危險因素的 Logistic 分析及護理干預. 中國藥物與臨床, 2014, 14(3): 300-302.
|
| 20. |
Ohi M, Toiyama Y, Omura Y, et al. Risk factors and measures of pulmonary complications after thoracoscopic esophagectomy for esophageal cancer. Surg Today, 2019, 49(2): 176-186.
|
| 21. |
田燁, 周凌霄, 任光國. 1208 例食管癌患者術后吻合口瘺風險因素分析. 重慶醫學, 2014, 43(15): 1924-1927.
|
| 22. |
沈偉忠, 黃建峰. 食管癌術后心律失常危險因素分析. 中國腫瘤外科雜志, 2015, 7(6): 384-386.
|
| 23. |
楊澤山. 431 例老年食管癌患者術后肺部并發癥情況及危險因素分析. 中華全科醫學, 2015, 13(11): 1779-1781, 1868.
|
| 24. |
楊立新, 梁偉, 于嬋娟, 等. 胸腹腔鏡聯合食管癌根治術后肺部并發癥的危險因素分析. 臨床外科雜志, 2017, 25(7): 512-515.
|
| 25. |
許冰. 食管癌、賁門癌術后心律失常的原因分析. 腫瘤基礎與臨床, 2012, 25(1): 40-42.
|
| 26. |
郝棟, 劉國魁, 邱新民. 低肺功能食管癌高齡患者的圍術期治療探討. 白求恩軍醫學院學報, 2009, 7(4): 219-220.
|
| 27. |
沙紀名, 林澤邦, 徐盛松, 等. 臨界肺功能食管癌患者微創手術的臨床療效研究. 安徽醫學, 2019, 40(8): 917-920.
|
| 28. |
Noguchi T, Shichinohe T, Hirano S, et al. Minimally invasive esophagectomy for cancer patients with low pulmonary function. Hepatogastroenterology, 2010, 57(101): 768-771.
|